A phase II study of biweekly paclitaxel and S-1 (SPA) as first-line combination therapy in patients with metastatic or locally advanced gastric cancer.
Haiping Jiang
No relevant relationships to disclose
Yulong Zheng
No relevant relationships to disclose
Jiong Qian
No relevant relationships to disclose
Xiaochen Zhang
No relevant relationships to disclose
Haibo Mou
No relevant relationships to disclose
Peng Zhao
No relevant relationships to disclose
Chenyu Mao
No relevant relationships to disclose
Yi Zheng
No relevant relationships to disclose
Yao Wang
No relevant relationships to disclose
Lan Fang Yu
No relevant relationships to disclose
Jing Deng
No relevant relationships to disclose
Weijiang Fang
No relevant relationships to disclose
Nong Xu
No relevant relationships to disclose